GWN Securities Inc. Purchases New Holdings in Cardinal Health, Inc. (NYSE:CAH)

GWN Securities Inc. bought a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,360 shares of the company's stock, valued at approximately $1,461,000.

Several other hedge funds have also bought and sold shares of the stock. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Cardinal Health by 35.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock worth $3,871,000 after purchasing an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp boosted its stake in Cardinal Health by 1.5% in the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock worth $28,435,000 after buying an additional 3,576 shares in the last quarter. Geode Capital Management LLC grew its position in Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after acquiring an additional 42,082 shares during the last quarter. Consolidated Planning Corp raised its stake in shares of Cardinal Health by 40.0% during the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock worth $1,056,000 after acquiring an additional 2,552 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Cardinal Health by 2.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company's stock worth $162,976,000 after acquiring an additional 33,388 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Remove Ads

Cardinal Health Stock Up 0.7 %

Shares of NYSE:CAH traded up $0.90 on Thursday, hitting $133.02. The company had a trading volume of 1,788,563 shares, compared to its average volume of 1,962,841. The firm's 50-day simple moving average is $126.94 and its two-hundred day simple moving average is $119.78. The firm has a market capitalization of $32.13 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $133.08.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.52%. Cardinal Health's dividend payout ratio is presently 37.69%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of analyst reports. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a research note on Tuesday, January 7th. Citigroup raised their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research report on Friday, January 10th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Argus set a $148.00 target price on shares of Cardinal Health in a report on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.